$1.16 Billion is the total value of Antipodean Advisors LLC's 25 reported holdings in Q4 2013. The portfolio turnover from Q3 2013 to Q4 2013 was 71.4% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
VRX | Sell | VALEANT PHARMACEUTICALS INTL | $108,853,000 | -5.1% | 927,200 | -15.7% | 9.42% | -21.3% |
CHTR | Sell | CHARTER COMMUNICATIONS INC Dcl a new | $104,758,000 | -2.7% | 766,000 | -4.1% | 9.06% | -19.3% |
HRB | Sell | BLOCK H & R INC | $57,505,000 | -14.9% | 1,980,200 | -21.9% | 4.98% | -29.4% |
GRA | Sell | GRACE W R & CO DEL NEW | $34,506,000 | -3.0% | 349,000 | -14.3% | 2.98% | -19.6% |
FB | Sell | FACEBOOK INCcl a | $32,434,000 | -48.7% | 593,500 | -52.8% | 2.81% | -57.4% |
LOW | Sell | LOWES COS INC | $32,009,000 | -13.4% | 646,000 | -16.8% | 2.77% | -28.2% |
JCPNQ | Exit | PENNEY J C INC | $0 | – | -400,000 | -100.0% | -0.37% | – |
BB | Exit | BLACKBERRY LTD | $0 | – | -631,000 | -100.0% | -0.52% | – |
FRAN | Exit | FRANCESCAS HLDGS CORP | $0 | – | -376,000 | -100.0% | -0.73% | – |
ACT | Exit | ACTAVIS INC | $0 | – | -71,000 | -100.0% | -1.07% | – |
ALXN | Exit | ALEXION PHARMACEUTICALS INC | $0 | – | -111,911 | -100.0% | -1.36% | – |
GRFS | Exit | GRIFOLS S Asp adr rep b nvt | $0 | – | -462,455 | -100.0% | -1.46% | – |
AN | Exit | AUTONATION INC | $0 | – | -384,000 | -100.0% | -2.09% | – |
UAL | Exit | UNITED CONTL HLDGS INC | $0 | – | -654,000 | -100.0% | -2.10% | – |
KORS | Exit | MICHAEL KORS HOLDINGS LTD | $0 | – | -278,000 | -100.0% | -2.16% | – |
LBTYK | Exit | LIBERTY GLOBAL PLC | $0 | – | -278,000 | -100.0% | -2.19% | – |
AEGR | Exit | AEGERION PHARMACEUTICALS INC | $0 | – | -266,400 | -100.0% | -2.38% | – |
SIRI | Exit | SIRIUS XM RADIO INC | $0 | – | -6,392,000 | -100.0% | -2.58% | – |
DISH | Exit | DISH NETWORK CORPcl a | $0 | – | -734,000 | -100.0% | -3.45% | – |
YHOO | Exit | YAHOO INC | $0 | – | -1,084,000 | -100.0% | -3.75% | – |
SEAS | Exit | SEAWORLD ENTMT INC | $0 | – | -1,302,073 | -100.0% | -4.02% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-02-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
CARVANA CO | 21 | Q2 2023 | 38.5% |
AMAZON COM INC | 20 | Q4 2020 | 33.8% |
SEA LTD | 19 | Q3 2023 | 60.8% |
CARDLYTICS INC | 18 | Q3 2023 | 26.3% |
MEDICINES CO | 18 | Q4 2019 | 19.8% |
ATARA BIOTHERAPEUTICS INC | 15 | Q3 2023 | 17.9% |
CONSTELLATION BRANDS INC | 14 | Q4 2016 | 11.1% |
HERBALIFE NUTRITION LTD | 13 | Q1 2021 | 24.8% |
CLARIVATE PLC | 11 | Q4 2021 | 24.4% |
EXACT SCIENCES CORP | 11 | Q2 2019 | 24.6% |
View Antipodean Advisors LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Oncothyreon Inc.Sold out | January 09, 2013 | 0 | 0.0% |
View Antipodean Advisors LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-13 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-14 |
13F-HR | 2021-11-15 |
13F-HR | 2021-08-16 |
View Antipodean Advisors LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.